European Neuropsychopharmacology
Volume 20, Issue 5 , Pages 310-316 , May 2010

Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST)

  • Wolfgang Gaebel

      Affiliations

    • Department of Psychiatry and Psychotherapy, Heinrich-Heine-University Düsseldorf, Rhineland State Clinics Düsseldorf, Germany
    • Corresponding Author InformationCorresponding author. Department of Psychiatry and Psychotherapy, Heinrich-Heine-University Düsseldorf, Rhineland State Clinics Düsseldorf, Bergische Landstraße 2, D-40629 Düsseldorf, Germany. Tel.: +49 211 922 2000; fax: +49 211 922 2020.
    • ,
  • Mathias Riesbeck

      Affiliations

    • Department of Psychiatry and Psychotherapy, Heinrich-Heine-University Düsseldorf, Rhineland State Clinics Düsseldorf, Germany
    • ,
  • Martina von Wilmsdorff

      Affiliations

    • Department of Psychiatry and Psychotherapy, Heinrich-Heine-University Düsseldorf, Rhineland State Clinics Düsseldorf, Germany
    • ,
  • Tom Burns

      Affiliations

    • Department of Psychiatry, University of Oxford, UK
    • ,
  • Eske M. Derks

      Affiliations

    • Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, The Netherlands
    • ,
  • René S. Kahn

      Affiliations

    • Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, The Netherlands
    • ,
  • Wulf Rössler

      Affiliations

    • Psychiatric University Hospital Zurich, Switzerland
    • ,
  • W. Wolfgang Fleischhacker

      Affiliations

    • Department of Biological Psychiatry, Medical University Innsbruck, Austria
    • ,
  • for the EUFEST Study Group

Received 3 December 2009 ,Revised 14 January 2010 ,Accepted 3 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0924-977X(10)00020-9

doi: 10.1016/j.euroneuro.2010.02.001

European Neuropsychopharmacology
Volume 20, Issue 5 , Pages 310-316 , May 2010

Article Tools

* Image Usage & Resolution